OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular disease in patients with severe mental illness
René Ernst Nielsen, Jytte Banner, Svend Eggert Jensen
Nature Reviews Cardiology (2020) Vol. 18, Iss. 2, pp. 136-145
Closed Access | Times Cited: 263

Showing 1-25 of 263 citing articles:

Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors
Christoph U. Correll, Marco Solmi, Giovanni Croatto, et al.
World Psychiatry (2022) Vol. 21, Iss. 2, pp. 248-271
Open Access | Times Cited: 368

Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images
Bingxin Zhao, Tengfei Li, Zirui Fan, et al.
Science (2023) Vol. 380, Iss. 6648
Closed Access | Times Cited: 115

Severe Mental Illness and Cardiovascular Disease
Michael Goldfarb, Marc D. Binder, Johan Detraux, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 9, pp. 918-933
Open Access | Times Cited: 89

Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24

Stress and cardiovascular disease: an update
Viola Vaccarino, J. Douglas Bremner
Nature Reviews Cardiology (2024) Vol. 21, Iss. 9, pp. 603-616
Closed Access | Times Cited: 21

Severe mental illness: cardiovascular risk assessment and management
Christoffer Polcwiartek, Kevin O’Gallagher, Daniel J. Friedman, et al.
European Heart Journal (2024) Vol. 45, Iss. 12, pp. 987-997
Open Access | Times Cited: 20

From Lab to Life: Exploring Cutting-Edge Models for Neurological and Psychiatric Disorders
Masaru Tanaka, László Vécsei
Biomedicines (2024) Vol. 12, Iss. 3, pp. 613-613
Open Access | Times Cited: 19

Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies
Marco Solmi, Jess G. Fiedorowicz, Laura Poddighe, et al.
American Journal of Psychiatry (2021) Vol. 178, Iss. 9, pp. 793-803
Open Access | Times Cited: 93

Mortality gap and physical comorbidity of people with severe mental disorders: the public health scandal
Andrea Fiorillo, Norman Sartorius
Annals of General Psychiatry (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 71

Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study
Christoph U. Correll, Kenneth S. Koblan, Seth C. Hopkins, et al.
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 69

Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort study
Lin Li, Zheng Chang, Jiangwei Sun, et al.
World Psychiatry (2022) Vol. 21, Iss. 3, pp. 452-459
Open Access | Times Cited: 55

Efficient Model for Coronary Artery Disease Diagnosis: A Comparative Study of Several Machine Learning Algorithms
Ali Garavand, Cirruse Salehnasab, Ali Behmanesh, et al.
Journal of Healthcare Engineering (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 51

Risk factors for clozapine‐induced myocarditis and cardiomyopathy: A systematic review and meta‐analysis
Mark L. Vickers, Vinay Ramineni, Eva Malacova, et al.
Acta Psychiatrica Scandinavica (2022) Vol. 145, Iss. 5, pp. 442-455
Closed Access | Times Cited: 49

Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countries
Qing Shen, Dorte Helenius Mikkelsen, Laura Birgit Luitva, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102063-102063
Open Access | Times Cited: 27

New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment
Pawan Faris, Doris Pischedda, Fulvia Palesi, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 9

Immunophenotypes in psychosis: is it a premature inflamm-aging disorder?
Song Chen, Yunlong Tan, Li Tian
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2834-2848
Open Access | Times Cited: 8

Atypical antipsychotic drugs cause abnormal glucose and lipid metabolism independent of weight gain
Ye Yang, Renrong Wu
European Archives of Psychiatry and Clinical Neuroscience (2025)
Closed Access | Times Cited: 1

Exploring the Relationship Between Schizophrenia and Cardiovascular Disease: A Genetic Correlation and Multivariable Mendelian Randomization Study
Rada R Veeneman, Jentien M. Vermeulen, Abdel Abdellaoui, et al.
Schizophrenia Bulletin (2021) Vol. 48, Iss. 2, pp. 463-473
Open Access | Times Cited: 51

Coronary Heart Disease and Depression or Anxiety: A Bibliometric Analysis
Yan Zhou, Xueping Zhu, Jingjing Shi, et al.
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 50

The increased ratio of Mg2+/Ca2+ from degrading magnesium alloys directs macrophage fate for functionalized growth of endothelial cells
Yachen Hou, Frank Witte, Jingan Li, et al.
Smart Materials in Medicine (2022) Vol. 3, pp. 188-198
Open Access | Times Cited: 36

Climate change and the prevention of cardiovascular disease
Alan P. Jacobsen, Yii Chun Khiew, Eamon Duffy, et al.
American Journal of Preventive Cardiology (2022) Vol. 12, pp. 100391-100391
Open Access | Times Cited: 35

Page 1 - Next Page

Scroll to top